Liu XQ, Zhang YF, Ding HY, Yan MM, et al. Rationale and design of a prospective study evaluating population pharmacokinetics and pharmacodynamics of rivaroxaban in Chinese patients with non-valvular atrial fibrillation. BMJ Open 2022;12:e058378.
PMID: 36691239